Chromium infusion reverses extreme insulin resistance in a cardiothoracic ICU patient

Michael Via, Corey Scurlock, Jayashree Raikhelkar, Gabriele Di Luozzo, Jeffrey I. Mechanick

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Insulin resistance is common and often multifactorial in acutely critically ill patients. At our institution, glycemic control is achieved in these patients using an intravenous insulin protocol. The authors present a case in which a patient developed severe insulin resistance following surgical repair of a thoracic aorta aneurysm. Postoperatively, the patient required 2110 units of insulin over 40 hours while receiving pressors and glucocorticoids. After the administration of intravenous chromium at 3 g/h, the blood sugar normalized and insulin therapy was discontinued. This case represents a unique approach using intravenous chromium to achieve glycemic control in a patient with extreme insulin resistance and acute critical illness. Prospective clinical trials using intravenous chromium may provide the means to optimize intensive insulin therapy for critically ill patients.

Original languageEnglish
Pages (from-to)325-328
Number of pages4
JournalNutrition in Clinical Practice
Issue number3
StatePublished - Jun 2008


  • Chromium
  • Critical illness
  • Glucose intolerance
  • Hyperglycemia
  • Insulin
  • Insulin resistance


Dive into the research topics of 'Chromium infusion reverses extreme insulin resistance in a cardiothoracic ICU patient'. Together they form a unique fingerprint.

Cite this